Pleurodesis with a combination of OK-432 and adriamycin for malignant pleural effusions caused by lung cancer

Japanese Journal of Lung Cancer

Volumn 39, Issue 3, 1999, Pages 261-266

  Kishi, Kazuma ^a   Kaivabata, Masateru ^a   Tsuboi, Eiyasu ^a   Nanti, Koji ^a   Homma, Sakae ^a   Nakatani, Tatsuo ^a   Nakata, Koichiro ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Adriamycin; Lung cancer; Malignant pleural effusion; OK 432; Pleurodesis

Indexed keywords

DOXORUBICIN; PICIBANIL;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; FEVER; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAPLEURAL DRUG ADMINISTRATION; LARGE CELL CARCINOMA; LEUKOPENIA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PLEURA EFFUSION; PLEURODESIS; THORAX DRAINAGE; THORAX PAIN; THROMBOCYTOPENIA; VOMITING;

EID: 0032808297     PISSN: 03869628     EISSN: None     Source Type: Journal    
DOI: 10.2482/haigan.39.261     Document Type: Article

References (12)

1. Walker-Renard PB, Vaughan LM, Sahn SA : Chemical pleurodesis for malignant pleural effusion. Ann Intern Med 120 : 56-64,1994.
2. Saka H, Shimokata K, Watanabe A, et al : Interim analysis of randomized trial of OK432 vs. bleomycin in malignant pleural effusion : a Nagoya Oncology Group Study. Proc. ASCO 11 : 389, 1992.
3. Luh KT, Yang PC, Kuo SH, et al : Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. Cancer 69 : 674-679, 1992.
4. Graveryn TR, Michelson MK, Gross BH, et al : Tetracycline pleurodesis for malignant pleural effusions. Cancer 59 :1973-1977,1987.